|
|||||
|
|
Raised HDL cholesterol in Fabry disease: Response to enzyme replacement therapy |
|
| Authors: | D. J. Cartwright A. L. Cole A. J. Cousins P. J. Lee |
| Affiliation: | Charles Dent Metabolic Unit, National Hospital for Neurology and Neurosurgery, London, UK. |
| Abstract: | Fabry disease patients have increased risk of vascular disease despite cardioprotective increased HDL-cholesterol. Enzyme therapy does not significantly alter the lipid profile in the short term. |
| Keywords: | |
| 本文献已被 PubMed SpringerLink 等数据库收录！ | |